Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gut bacterium Intestinimonas butyriciproducens improves host metabolic health: evidence from cohort and animal intervention studies

20 Jan 2025

Abstract excerpt

BACKGROUND: The human gut microbiome strongly influences host metabolism by fermenting dietary components into metabolites that signal to the host. Our previous work has shown that Intestinimonas butyriciproducens is a prevalent commensal bacterium with the unique ability to convert dietary fructoselysine to butyrate, a well-known signaling molecule with proven health benefits. Dietary fructoselysine is an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Glycation End Products research
Share to Diet, Metabolism, and Disease
Share to Gut microbiota and health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39833973
DOI: 10.1186/s40168-024-02002-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gut bacterium Intestinimonas butyriciproducens improves host metabolic health: evidence from cohort and animal intervention studiesPMID 39833973Read ↗

Gut bacterium Intestinimonas butyriciproducens improves host metabolic health: evidence from cohort and animal intervention studiesSemantic proximity Read ↗

Fecal <i>Dysosmobacter</i> spp. concentration is linked to plasma lipidome in insulin-resistant individuals with overweight, obesity and metabolic syndromeSemantic proximity Read ↗

A Keystone Gut Bacterium Christensenella minuta—A Potential Biotherapeutic Agent for Obesity and Associated Metabolic DiseasesSemantic proximity Read ↗

Cross-feeding-based rational design of a probiotic combination of Bacterides xylanisolvens and Clostridium butyricum therapy for metabolic diseasesSemantic proximity Read ↗

Fructose catabolism and its metabolic effects: Exploring host–microbiota interactions and the impact of ethnicitySemantic proximity Read ↗

Fermentation potential of the gut microbiome: implications for energy homeostasis and weight managementSemantic proximity Read ↗

Bifidobacterium animalis subsp. lactis 420 for Metabolic Health: Review of the ResearchSemantic proximity Read ↗

The human-derived novel gut commensal Luoshenia tenuis regulates body weight and food intake in miceSemantic proximity Read ↗

Positive Interventional Effect of Engineered Butyrate-Producing Bacteria on Metabolic Disorders and Intestinal Flora Disruption in Obese MiceSemantic proximity Read ↗

Impact of a High-Fat Diet on the Gut Microbiome: A Comprehensive Study of Microbial and Metabolite Shifts During ObesitySemantic proximity Read ↗

Alternation of the gut microbiota in metabolically healthy obesity: An integrated multiomics analysisSemantic proximity Read ↗

Cross-tissue multiomics reveals that Akkermansia muciniphila counteracts metabolic syndrome by reprograming gut microbiota, oleoylethanolamide and the gut-hypothalamus axisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.